Skip to main content

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PRINCETON, N.J., Sept. 04, 2026 (GLOBE NEWSWIRE) — UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced the grants of inducement restricted stock units (“RSUs”) to 19 new employees in connection with their employment with UroGen. These new team members will support the ongoing commercialization of JELMYTO® (mitomycin) for pyelocalyceal solution and ZUSDURI™ (mitomycin) for intravesical solution, UroGen’s only approved products, and the continued development of UroGen’s pipeline. Up to 117,100 ordinary shares of UroGen are issuable upon the vesting and settlement of the RSUs. The RSUs will vest equally over three years, with one-third of the underlying shares vesting each year on the anniversary of...

Continue reading

Hurco Reports Profit in Third Quarter Results for Fiscal Year 2026

INDIANAPOLIS, Sept. 04, 2026 (GLOBE NEWSWIRE) — Hurco Companies, Inc. (Nasdaq: HURC) today reported results for the third fiscal quarter ended July 31, 2026. Hurco recorded net income of $2,314,000, or $0.35 per diluted share, for the third quarter of fiscal year 2026, compared to a net loss of $3,693,000, or $(0.58) per diluted share, for the corresponding period in fiscal year 2025. For the first nine months of fiscal year 2026, Hurco reported a net loss of $3,526,000, or $(0.55) per diluted share, compared to a net loss of $12,076,000, or $(1.87) per diluted share, for the corresponding period in fiscal year 2025. Sales and service fees for the third quarter of fiscal year 2026 were $47,289,000, an increase of $1,483,000, or 3%, compared to the corresponding prior year period, and included an unfavorable currency impact of $20,000,...

Continue reading

Statement: EdgeMode confirms that the current review process with BlackBerry AIF and BLACK AI Group will be extended for up to six months

FORT LAUDERDALE, Fla., Sept. 04, 2026 (GLOBE NEWSWIRE) — EdgeMode, Inc. (OTC: EDGM) today announces that, by mutual agreement with BlackBerry AIF and BLACK AI Group, the current review process between the parties will be extended for an additional period of up to six months. During this period, BLACK AI Group will continue to advance independently with the development of its AI infrastructure platform, including its large-scale data center projects, strategic partnerships, and financing strategy. The parties remain aligned around the opportunities within the AI infrastructure sector and will use this additional period to complete their strategic, corporate, and commercial review, while EdgeMode undertakes the internal corporate, financial, and strategic work required to support any potential future transaction. Potential structures...

Continue reading

Edible Garden Launches First-to-Market USDA Organic CEA-Grown Basil at Wakefern/ShopRite

Exclusive Program Expands ShopRite Distribution Ahead of Labor Day Utilizes Wakefern Backhaul Network to Enhance Supply-Chain Efficiency, Reduce Food Miles and Support Edible Garden’s Zero-Waste Inspired® Mission BELVIDERE, NJ, Sept. 04, 2026 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), organic and sustainable produce, and developer of the Zero-Waste Inspired® mission and Farm-to-Formula® platform today announced that it has begun shipping what the Company believes to be the CEA industry’s first verified USDA Organic basil to Wakefern Food Corp. for distribution to participating ShopRite stores as part of an exclusive program. The expanded distribution comes ahead of Labor Day weekend, a period of increased demand...

Continue reading

SUTNTIB AB Tewox publishes its NAV for August 2026

Vilnius, Lithuania, Sept. 04, 2026 (GLOBE NEWSWIRE) — As at the end of August 2026, the net asset value (NAV) of SUTNTIB AB Tewox decreased to EUR 45,190,557, compared to the previously determined NAV of EUR 45,671,734 at the end of July 2026. The share price decreased to EUR 1.0795, from EUR 1.0910 at the end of July 2026. The pro-forma internal rate of return (IRR) decreased to 3.51%, compared to previously announced IRR of 3.81% at the end of July 2026. Contact person for further information: Paulius NevinskasManager of the Investment Companypaulius.nevinskas@lordslb.lthttps://lordslb.lt/tewox_bonds/

Continue reading

OSB GROUP PLC – Holding(s) in Company

TR-1: Standard form for notification of major holdings 1.  Issuer Details ISIN GB00BLDRH360 Issuer Name OSB GROUP PLC UK or Non-UK Issuer UK 2.  Reason for Notification An acquisition or disposal of voting rights 3.  Details of person subject to the notification obligation Name Lorentzweiler Adjacent Partners S.C.Sp. City of registered office (if applicable) Howald Country of registered office (if applicable) Luxembourg 4.  Details of the shareholder Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above City of registered office (if applicable) Country of registered office (if applicable) 5.  Date on which the threshold was crossed or reached 01-Sep-2026 6.  Date on which Issuer notified 03-Sep-2026 7.  Total positions of person(s) subject to the notification...

Continue reading

Auction result of Treasury Bonds – RIKB 29 0416 – RIKB 42 0217

Series  RIKB 29 0416 RIKB 42 0217Settlement Date  09/09/2026 09/09/2026Total Amount Allocated (MM)  3,400 5,980All Bids Awarded At (Price / Yield)  99.855 / 7.780 78.795 / 6.750Total Number of Bids Received  21 33Total Amount of All Bids Received (MM)  9,400 8,910Total Number of Successful Bids  13 20Number of Bids Allocated in Full  13 20Lowest Price / Highest Yield Allocated  99.855 / 7.780 78.795 / 6.750Highest Price / Lowest Yield Allocated  99.950 / 7.740 78.950 / 6.730Lowest Price / Highest Yield Allocated in Full  99.855 / 7.780 78.795 / 6.750Weighted Average of Successful Bids (Price/Yield)  99.912 / 7.760 78.877 / 6.740Best Bid (Price / Yield)  99.950 / 7.740 78.950 / 6.730Worst Bid (Price / Yield)  99.771 / 7.820 78.420 / 6.800Weighted Average of All Bids Received (Price / Yield)  99.853 / 7.780 78.802 / 6.750Percentage...

Continue reading

Clearmind Medicine Signs Definitive Agreement to Acquire 51% Stake in Wireless Charging Company for Automated Parking and Robotaxis

Charging Robotics  is one of the few worldwide developing innovative wireless charging systems designed specifically for automated parking facilities and autonomous mobile platforms- environments where conventional cables and plug-in infrastructure cannot operate. Vancouver, Canada, Sept. 04, 2026 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation psychedelic, neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced that it has entered into a definitive agreement (“Agreement”) to acquire a 51% stake in Charging Robotics, an intelligent EV (electric vehicles) wireless charging solutions for automated parking systems and...

Continue reading

Brookfield Announces Intention to Redeem its Class A Preference Shares, Series 51 and 52

All amounts in Canadian dollars unless otherwise stated. BROOKFIELD, NEWS, Sept. 04, 2026 (GLOBE NEWSWIRE) — Brookfield Corporation (“Brookfield”) (NYSE: BN, TSX: BN) today announced that it intends to redeem all of its Cumulative Redeemable Class A Preference Shares, Series 51 (the “Series 51 Shares”) (TSX: BN.PF.K) and all of its Cumulative Redeemable Class A Preference Shares, Series 52 (the “Series 52 Shares”) (TSX: BN.PF.L) for cash on November 1, 2026 (the “Redemption Date”). The redemption price for each Series 51 Share will be $22.44, together with all accrued and unpaid dividends up to but excluding the Redemption Date. The redemption price for each Series 52 Share will be $22.00. Holders of the Series 52 Shares of record as of October 15, 2026 will also receive the previously declared final quarterly dividend of $0.151250...

Continue reading

Nykredit Realkredit A/S publish supplement no 1 to joint Euro Medium Term Note Programme

To Nasdaq Copenhagen Nykredit Realkredit A/S publish supplement no 1 to joint Euro Medium Term Note Programme Nykredit Realkredit A/S publish supplement no 1 dated 4 September 2026 to joint €15,000,000,000 Euro Medium Term Note Programme (“EMTN Programme“) dated 8 May 2026. Under the EMTN Programme Nykredit Realkredit A/S may issue Subordinated Notes (Tier 2), Senior Non-Preferred Notes and Senior Unsecured Notes. The supplement and the EMTN Programme are available for download on Nykredit’s website at nykredit.com/ir. Questions may be addressed to Morten Bækmand Nielsen, Head of ALM & Investor Relations, tel +45 44 55 15 21 or Frederik Bangshaab, Seniorspecialist, tel +45 44 55 45 62.AttachmentsNykredit Realkredit publish supplementSupplement for EMTN Progamme

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.